Bradda Head  Lithium exceeds targets, secures US$3 million royalty and moves closer to production. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBreedon Regulatory News (BREE)

Share Price Information for Breedon (BREE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 392.50
Bid: 391.50
Ask: 393.00
Change: 1.00 (0.26%)
Spread: 1.50 (0.383%)
Open: 391.00
High: 396.50
Low: 391.00
Prev. Close: 391.50
BREE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of AGM

20 Apr 2021 14:36

RNS Number : 0680W
Breedon Group PLC
20 April 2021
 

 

 

20 April 2021

Breedon Group plc

("Breedon Group" or the "Company")

 

Result of AGM

 

The Annual General Meeting of Breedon Group plc (the "Meeting") was held on Tuesday 20 April 2021 as a closed meeting at Pinnacle House, Breedon Quarry, Breedon on the Hill, DE73 8AP at 2.00pm.

All resolutions proposed at the meeting were passed on a show of hands. The number of votes which were lodged by proxy for and against each of the resolutions put before the Meeting, and the number of votes withheld, were as follows:

 

Votes for

% of shares voted

Votes against

Votes total

Votes withheld

Ordinary Resolutions

1

To adopt the Financial Statements and the reports of the Directors and of the Auditor for the year ended

31 December 2020

1,337,175,133

100.00

5,842

1,337,180,975

1,530,067

2

To reappoint the Auditor

1,326,393,752

99.09

12,211,017

1,338,604,769

106,273

3

To authorise the Directors to determine the fee payable to the Auditor

1,338,674,823

100.00

29,154

1,338,703,977

7,065

4

To approve the Directors' Remuneration Report

1,292,423,212

96.55

46,167,056

1,338,590,268

120,774

5

To approve the amended Breedon Group Performance Share Plan rules

1,308,779,954

97.77

29,901,048

1,338,681,002

30,040

6

To reappoint James Brotherton as a director

1,334,813,513

99.84

2,089,060

1,336,902,573

1,808,469

7

To reappoint Helen Miles as a director

1,336,896,731

100.00

5,842

1,336,902,573

1,808,469

8

To reappoint Amit Bhatia as a director

1,321,490,326

98.85

15,412,247

1,336,902,573

1,808,469

9

To reappoint Carol Hui as a director

1,335,310,181

99.88

1,592,392

1,336,902,573

1,808,469

10

To reappoint Moni Mannings as a director

1,335,302,605

99.88

1,599,968

1,336,902,573

1,808,469

11

To reappoint Clive Watson as a director

1,311,437,042

98.10

25,465,531

1,336,902,573

1,808,469

12

To reappoint Rob Wood as a director

1,334,813,513

99.84

2,089,060

1,336,902,573

1,808,469

13

To authorise the Directors to allot shares

1,337,626,872

99.92

1,077,328

1,338,704,200

6,842

 

Special Resolutions

14

To disapply pre-emption rights in relation to the allotment of shares

1,320,930,368

98.67

17,776,118

1,338,706,486

4,556

15

To authorise the Directors to allot shares issued for an acquisition without applying pre-emption rights

1,293,155,493

96.60

45,526,818

1,338,682,311

28,731

16

To authorise the Company to purchase its own shares

1,324,362,218

98.97

13,844,804

1,338,207,022

504,020

 

Notes:

1 "Votes for" include those giving the Chairman discretion, and the percentages are rounded to two decimal places.

2 "Votes withheld" are not votes in law, and are not included in the votes "for" or "against" a resolution.

3 The total number of ordinary shares eligible to vote was 1,687,583,421.

 

Enquiries:

 

Breedon Group plc

Rob Wood, Chief Executive Officer

James Brotherton, Chief Financial Officer

Robert Coates, Head of Investor Relations

 

Numis Securities (NOMAD and Joint Broker)

Ben Stoop

Oliver Hardy (NOMAD)

 

HSBC (Joint Broker)

Sam McLennan

Joe Weaving

 

Teneo (Public Relations Adviser)

Matt Denham

Claire Scicluna

 

01332 694010

 

 

07880 486329

 

020 7260 1000

 

 

 

020 7991 8888

 

 

 

020 7420 3180

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGIMMJTMTJTBAB
Date   Source Headline
31st Jul 202311:36 amRNSTotal Voting Rights
26th Jul 20237:00 amRNSInterim results 2023
3rd Jul 20231:55 pmRNSNotice of Interim Results 2023
30th Jun 20239:55 amRNSTotal Voting Rights
27th Jun 202311:48 amRNSBlock Listing of Ordinary Shares
13th Jun 202310:51 amRNSReduction of Capital Effective
6th Jun 20235:02 pmRNSOutcome of Court Hearing on Reduction of Capital
2nd Jun 20233:25 pmRNSHolding(s) in Company
1st Jun 202310:37 amRNSHolding(s) in Company
31st May 202312:35 pmRNSTotal Voting Rights
31st May 202311:30 amRNSHolding(s) in Company
24th May 202312:35 pmRNSDirector/PDMR Shareholding
23rd May 20235:31 pmRNSHolding(s) in Company
22nd May 202311:24 amRNSHolding(s) in Company
19th May 20237:00 amRNSHolding(s) in Company
19th May 20237:00 amRNSHolding(s) in Company
19th May 20237:00 amRNSHolding(s) in Company
18th May 20234:52 pmRNSDirector/PDMR Shareholding
18th May 20239:00 amRNSBreedon plays key role in Peak Cluster initiative
18th May 20238:00 amRNSAcquisitions
17th May 20238:00 amRNSReadmission - Breedon Group plc
17th May 20237:00 amRNSAdmission to Main Market
12th May 20236:00 pmRNSBreedon Group
12th May 20233:50 pmRNSDirector/PDMR Shareholding
11th May 202312:56 pmRNSPublication of Prospectus
4th May 202310:06 amRNSHolding(s) in Company
28th Apr 20237:00 amRNSHolding(s) in Company
26th Apr 20234:41 pmRNSResult of Scheme Meetings & Annual General Meeting
26th Apr 20237:00 amRNSAGM Trading Update
24th Apr 20232:22 pmRNSHolding(s) in Company
13th Apr 20236:08 pmRNSHolding(s) in Company
13th Apr 202312:12 pmRNSHolding(s) in Company
12th Apr 20234:50 pmRNSDirector/PDMR Shareholding
29th Mar 20237:00 amRNSPublication of Scheme Document
24th Mar 20233:49 pmRNSHolding(s) in Company
20th Mar 20239:00 amRNS2022 Annual Report and Notice of AGM
10th Mar 20235:34 pmRNSHolding(s) in Company
10th Mar 20237:00 amRNSResults of Reverse Accelerated Bookbuild
9th Mar 20234:56 pmRNSStatement re Reverse Accelerated Bookbuild
9th Mar 20231:36 pmRNSDirector/PDMR Shareholding
8th Mar 20237:00 amRNSIntention to move from AIM to the Main Market
8th Mar 20237:00 amRNSFinal Results
8th Feb 20238:00 amRNSNotice of Results
6th Feb 20231:29 pmRNSDirector/PDMR Shareholding
6th Jan 202310:08 amRNSBlocklisting Update
23rd Dec 202210:00 amRNSTotal Voting Rights
19th Dec 202212:57 pmRNSHolding(s) in Company
2nd Dec 20224:01 pmRNSHolding(s) in Company
30th Nov 20229:28 amRNSTotal Voting Rights
25th Nov 20227:00 amRNSNovember trading statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.